Nan Wang is a legal and compliance professional with a strong background in the pharmaceutical industry. They served as an Associate at Kobre & Kim from 2016 to 2020, specializing in cross-border disputes and internal investigations related to the Foreign Corrupt Practices Act. Currently, Wang holds the position of Executive Director, Ethics & Compliance Core Capabilities/Business Partner at Eli Lilly and Company, where they advance compliance programs and provide strategic support to the Central Marketing Organization. Wang also possesses academic experience as a Teaching Assistant at the University of Wisconsin Law School, where they instructed LL.M students in American law. They earned a Bachelor of Law in Economic Law from East China University of Political Science and Law, followed by both a Master of Legal Institution and a Juris Doctor from the University of Wisconsin Law School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices